Showing results (131-140 of 174) with videos related to
Sort By:
Pageof 18
Hepatology (Baltimore, Md.)|August 24, 2019
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic AdaptationFei Chen, Saeed Esmaili, Geraint B Rogers, et al.Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 28, 2024
Integrated analysis reveals that miR-548ab promotes the development of obesity and T2DMChongge Pan, Yali Hou, Yanting Hou, et al.Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.Plos One|December 11, 2020
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver diseaseAli Bayoumi, Ismail Jalil, Mayada Metwally, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver diseaseStefania Grimaudo, Paola Dongiovanni, Jussi Pihlajamäki, et al.Journal of Hepatology|November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTRMayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.Hepatology (Baltimore, Md.)|July 18, 2018
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisSamuel J Daniels, Diana J Leeming, Mohammed Eslam, et al.Pageof 18